Interestingly, an increasing trend in the use of NST was observed, reaching a peak of 64% in the 2020–2022 period, coinciding with the most recent therapeutic advancements in this setting [ 14 , 15 ].
← all excerpts
Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece-The TRINITY Study.
1
—
—